News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Auspex Pharmaceuticals Signs Deal with Teva Pharmaceutical Industries Limited (TEVA) Involving a Deuterium-Containing Drug



12/21/2010 8:41:53 AM

VISTA, Calif.--(BUSINESS WIRE)--Auspex Pharmaceuticals, Inc. (www.auspexpharma.com) announced today that it has signed a deal involving a promising deuterium-containing drug with Teva Pharmaceutical Industries, Ltd. The discovery and initial development of the program subject to this transaction was conducted at Auspex Pharmaceuticals. Terms of the transaction were not disclosed.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES